Patterns of Regional Gray Matter and White Matter Atrophy in Patients Starting Fingolimod or Natalizumab: A 2-Year Tensor-Based Morphometry Study (P1.377)

Paolo Preziosa; Maria A. Rocca; Mariaemma Rodegher; Lucia Moiola; Andrea Falini; Gıancarlo Comı; Massimo Filippi

doi:10.1212/wnl.90.15_supplement.p1.377

Back

Patterns of Regional Gray Matter and White Matter Atrophy in Patients Starting Fingolimod or Natalizumab: A 2-Year Tensor-Based Morphometry Study (P1.377)

Article 2018 en

Abstract

1 min read

To compare the effects of fingolimod (FTY) and natalizumab (NAT) on preventing regional gray matter (GM) and white matter (WM) volume loss in relapsing-remitting multiple sclerosis (RRMS) after two years of treatment.

Related publications

Article2020

Patterns of Cerebellar Atrophy and Resting State Functional Connectivity Changes in Relapsing-Remitting MS Patients Starting Fingolimod and Natalizumab: A 2-Year Study (1314)

Paolo Preziosa, Paola Valsasina, Loredana Storelli, Elisabetta Pagani, Lucia Moiola, Mariaemma Rodegher, Maria A. Rocca, Massimo Filippi

Article2019

Modulation of Large-Scale Functional Networks Occurs in MS Patients Starting Fingolimod or Natalizumab: A 2-Year Resting State Functional Connectivity Study (S31.003)

Maria A. Rocca, Carlotta Marchetti, Paola Valsasina, Paolo Preziosa, Gianna Carla Riccitelli, Mariaemma Rodegher, Lucia Moiola, Giancarlo Comi, Massimo Filippi

Article2017

The Effects of Natalizumab and Fingolimod on Clinical and MRI Measures in Relapsing Remitting Multiple Sclerosis: A Two-Year Comparative Study (P2.073)

Paolo Preziosa, Maria A. Rocca, Gianna Carla Riccitelli, Mariaemma Rodegher, Lucia Moiola, Andrea Falini, Giancarlo Comi, Massimo Filippi

Article2015

The Effects of Natalizumab and Fingolimod on Clinical, Neuropsychological and MRI Measures in Relapsing Remitting Multiple Sclerosis: A One-Year Comparative Study (P6.152)

Paolo Preziosa, Maria A. Rocca, Gianna Carla Riccitelli, Mariaemma Rodegher, Massimiliano Copetti, Lucia Moiola, Francesco Mele, Andrea Falini, Giancarlo Comi, Massimo Filippi

Article2020

Effects of Fingolimod and Natalizumab on Brain T1/T2-Weighted and Magnetization Transfer Ratios: A 2-Year Study (1486)

Maria A. Rocca, Paolo Preziosa, Loredana Storelli, Lucia Moiola, Mariaemma Rodegher, Gıancarlo Comı, Massimo Filippi

Patterns of Regional Gray Matter and White Matter Atrophy in Patients Starting Fingolimod or Natalizumab: A 2-Year Tensor-Based Morphometry Study (P1.377)

Abstract

Discussion(0)

Related publications

Patterns of Cerebellar Atrophy and Resting State Functional Connectivity Changes in Relapsing-Remitting MS Patients Starting Fingolimod and Natalizumab: A 2-Year Study (1314)

Modulation of Large-Scale Functional Networks Occurs in MS Patients Starting Fingolimod or Natalizumab: A 2-Year Resting State Functional Connectivity Study (S31.003)

The Effects of Natalizumab and Fingolimod on Clinical and MRI Measures in Relapsing Remitting Multiple Sclerosis: A Two-Year Comparative Study (P2.073)

The Effects of Natalizumab and Fingolimod on Clinical, Neuropsychological and MRI Measures in Relapsing Remitting Multiple Sclerosis: A One-Year Comparative Study (P6.152)

Effects of Fingolimod and Natalizumab on Brain T1/T2-Weighted and Magnetization Transfer Ratios: A 2-Year Study (1486)